SummarySeveral research trends in contemporary psychiatry would benefit from greater emphasis on detailed assessment, modelling dynamic change, and micro-level analysis. This may assist with clarifying nosological and pathoaetiological issues. We make this case by referring to three areas: psychopathology and nosology; prediction research; and 'big N' data sets.
Declaration of interestNone. In this editorial, we argue that a number of tools used in contemporary psychiatric research, particularly in psychopathological assessment, are too blunt. The field would benefit from a greater emphasis on sharper, more detailed assessment and analysis; where there is great surface area, further depth could be introduced; where the 'macro' abounds, let us not forget the value of the 'micro'. This would enrich, balance and provide a corrective to several research trends, and possibly clarify nosological and pathoaetiological issues. We make this case by referring to three areas: psychopathology and nosology, prediction research and 'big N' data-sets.
Copyright and usage
Psychopathology and nosologyMuch recent work has questioned traditional diagnostic categories 1 and moved to identify domains of psychopathology and dimensions/continua that cut across diagnostic boundaries.2 This can be seen in the checklist-or atomistic-type approach to measuring signs and symptoms, 3 which have found significant overlap in psychotic and other symptoms across disorders (e.g. between schizophrenia and bipolar disorder 4 and between psychotic disorders and borderline personality disorder 5 ), as well as significant presence of 'symptoms' in general community (nonpatient) samples.2 The National Institute of Mental Health Research Domain Criteria signal a frustration with the DSM phenotypebased classification system and represent an attempt to base psychiatric nosology on neuroscience and behavioural science instead of descriptive phenomenology.6 These approaches promote the idea that phenotypes are far more overlapping and indistinct than traditionally thought, and that psychopathological domains can be measured quickly and simply in order to map on to the 'real' underlying pathology of neurobiological dysfunction. Just as an individual can be genotyped by running a DNA sequence with biological assays, their phenotype can be characterised through efficient (ideally self-report) measures that operationalise the array of psychiatric symptoms and signs.However, part of the frustration with phenotype-based classification and the perceived roadblock that it has introduced to research progress may be attributable not to phenotype-based classification per se, but rather to the oversimplified and broad nature of contemporary psychopathological description present in DSM-III onwards and many of the instruments used to measure psychopathology in research studies.7 What is required is perhaps not so much a discarding or downgrading of the centrality of phenotypes, but rather a resuscitation and refinement of psychopathological understanding and assessment...